Glutathione S-transferases variants as risk factors in Alzheimer's disease

Neurol Sci. 2015 Oct;36(10):1785-92. doi: 10.1007/s10072-015-2245-7. Epub 2015 May 17.

Abstract

Glutathione S-transferase (GST) was suggested as an important contributor to Alzheimer's disease (AD). The GSTs polymorphisms have been investigated as candidate genetic risk factors for AD, yet results remained uncertain. Therefore, we performed a meta-analysis to clarify the relationship of GSTs polymorphisms with the occurrence of AD. PubMed, Embase, Cochrane library and Alzgene databases were searched and potential literatures were selected. Pooled analyses and subgroup analyses were conducted, and also publication bias tests and cumulative meta-analysis. This meta-analysis suggested null associations between polymorphisms of GSTM1, GSTT1, GSTM3, GSTP1, GSTO1 and AD risk. GSTs variants may not have an impact on the morbidity of Alzheimer's disease. Further well designed researches are required to confirm these findings of the current study.

Keywords: Alzheimer’s disease; GSTM1; GSTM3; GSTO1; GSTP1; GSTT1; Meta-analysis; Polymorphism.

Publication types

  • Meta-Analysis

MeSH terms

  • Alzheimer Disease / epidemiology
  • Alzheimer Disease / genetics*
  • Genetic Predisposition to Disease*
  • Glutathione Transferase / genetics*
  • Humans
  • Polymorphism, Genetic*
  • Risk Factors

Substances

  • Glutathione Transferase